These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8190919

  • 1. [Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron-chelating therapy].
    Scutellari PN, Orzincolo C, Andraghetti D, Gamberini MR.
    Radiol Med; 1994 Apr; 87(4):389-96. PubMed ID: 8190919
    [Abstract] [Full Text] [Related]

  • 2. [The evolutionary effects of therapy on the skeletal lesions in beta-thalassemia].
    Orzincolo C, Castaldi G, Bariani L, Scutellari PN.
    Radiol Med; 1994 Apr; 87(4):381-8. PubMed ID: 8190918
    [Abstract] [Full Text] [Related]

  • 3. [Oromaxillofacial changes in thalassemia major].
    De Mattia D, Pettini PL, Sabato V, Rubini G, Laforgia A, Schettini F.
    Minerva Pediatr; 1996 Apr; 48(1-2):11-20. PubMed ID: 9072660
    [Abstract] [Full Text] [Related]

  • 4. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V.
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [Abstract] [Full Text] [Related]

  • 5. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C, La Nasa G, Contu L, Galimberti M, Polchi P, Angelucci E, Baronciani D, Barbanti I, Muretto P, Lucarelli G.
    Bone Marrow Transplant; 1993 Jul; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract] [Full Text] [Related]

  • 6. Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.
    Kattamis A, Kassou C, Berdousi H, Ladis V, Papassotiriou I, Kattamis C.
    Haematologica; 2003 Dec; 88(12):1423-5. PubMed ID: 14687998
    [No Abstract] [Full Text] [Related]

  • 7. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia.
    Tsironi M, Polonifi K, Deftereos S, Farmakis D, Andriopoulos P, Moyssakis I, Aessopos A.
    Eur J Haematol; 2005 Oct; 75(4):355-8. PubMed ID: 16146544
    [Abstract] [Full Text] [Related]

  • 8. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A, Kusuwan T, Limviriyakul S, Atipas S, Pooliam J, Sangpraypan T, Tanphaichitr VS, Viprakasit V.
    Hemoglobin; 2014 Oct; 38(5):345-50. PubMed ID: 25051423
    [Abstract] [Full Text] [Related]

  • 9. Intravenous chelation therapy during transplantation for thalassemia.
    Gaziev D, Giardini C, Angelucci E, Polchi P, Galimberti M, Baronciani D, Erer B, Maiello A, Lucarelli G.
    Haematologica; 1995 Oct; 80(4):300-4. PubMed ID: 7590497
    [Abstract] [Full Text] [Related]

  • 10. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.
    Blood Cells Mol Dis; 2009 Oct; 42(3):247-51. PubMed ID: 19233692
    [Abstract] [Full Text] [Related]

  • 11. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.
    Wang CH, Wu KH, Tsai FJ, Peng CT, Tsai CH.
    Hemoglobin; 2006 Oct; 30(2):257-62. PubMed ID: 16798651
    [Abstract] [Full Text] [Related]

  • 12. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia.
    Chan YL, Pang LM, Chik KW, Cheng JC, Li CK.
    Pediatr Radiol; 2002 Jul; 32(7):492-7. PubMed ID: 12107582
    [Abstract] [Full Text] [Related]

  • 13. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 14. Desferrioxamine-induced long bone changes in thalassaemic patients - radiographic features, prevalence and relations with growth.
    Chan YL, Li CK, Pang LM, Chik KW.
    Clin Radiol; 2000 Aug; 55(8):610-4. PubMed ID: 10964732
    [Abstract] [Full Text] [Related]

  • 15. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C, Zurlo MG, DeStefano P, Boffa C, DeSanctis V, DiPalma A, DiGregorio L, Melevendi C, Piga A, Sabato V.
    Bone Marrow Transplant; 1993 Aug; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract] [Full Text] [Related]

  • 16. [Arrhythmia in thalassemia major: evaluation of iron chelating therapy by dynamic ECG].
    Cavallaro L, Meo A, Busà G, Coglitore A, Sergi G, Satullo G, Donato A, Calabrò MP, Miceli M.
    Minerva Cardioangiol; 1993 Aug; 41(7-8):297-301. PubMed ID: 8233011
    [Abstract] [Full Text] [Related]

  • 17. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.
    Ann N Y Acad Sci; 2005 Aug; 1054():429-32. PubMed ID: 16339692
    [Abstract] [Full Text] [Related]

  • 18. Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients.
    Cassinerio E, Orofino N, Roghi A, Duca L, Poggiali E, Fraquelli M, Zanaboni L, Cappellini MD.
    Blood Cells Mol Dis; 2014 Sep; 53(3):164-7. PubMed ID: 24846580
    [Abstract] [Full Text] [Related]

  • 19. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
    Ha SY, Mok AS, Chu WC, Raskalkar DD, Cheuk DK, Chiang AK, Ho MH, Chan GC.
    Hemoglobin; 2009 Sep; 33(5):323-31. PubMed ID: 19814678
    [Abstract] [Full Text] [Related]

  • 20. Combined iron chelation therapy.
    Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW.
    Ann N Y Acad Sci; 2010 Aug; 1202():79-86. PubMed ID: 20712777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.